Paul E. Bender
Paul E. Bender publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and Reactions of Organic Compounds, Synthesis of heterocyclic compounds and Synthesis and biological activity.
- World rank
- #1,556,718 of 7,710,434 ranked researchers
- Rank in United States
- #485,827 of 1,627,098
- Works
- 51
- Citations
- 1.3k
- Citations per work
- 26.0
What does Paul E. Bender research?
Paul E. Bender's work is mostly in Chemistry (46%), Medicine (11%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2345.5%
- Chemistry2345.5%
- Everything else1528.8%
- Life Sciences714.4%
- Health Sciences611.3%
- Medicine611.3%
- 1Organic Chemistry42% of their works
- 2Molecular Biology11% of their works
- 3Pharmacology7% of their works
- 4Oncology4% of their works
- 5Physical and Theoretical Chemistry4% of their works
- 6Immunology4% of their works
Research topics
- Synthesis and Reactions of Organic Compounds
- Synthesis of heterocyclic compounds
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Inflammatory mediators and NSAID effects
- Synthesis and Characterization of Heterocyclic Compounds
- Cytokine Signaling Pathways and Interactions
- Asthma and respiratory diseases
Which keywords describe Paul E. Bender's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Catalyst, Inflammation, Heterocyclic Compounds, Medicinal Chemistry, Biological Evaluation and Cancer.
- Asthma
- Triazines
- IL-6
- Prostaglandins
- Vascular Targeting Agents
- Quinoxaline
- Oxazolones
- Imidazoles
- Cancer
- Medicinal Chemistry
- Inflammation
- Heterocycles
- Synthesis
- Catalyst
- Heterocyclic Compounds
- Biological Evaluation
- Annulation
- Ketene Dithioacetal
- Antimicrobial Activity
- Tubulin Inhibitors
- Cyclooxygenase-2 Inhibitors
- Antimicrobial
- STAT3
- Allergic Diseases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Synthesis284 topics
- Heterocycles213 topics
- Catalyst152 topics
- Inflammation153 topics
- Heterocyclic Compounds142 topics
- Medicinal Chemistry142 topics
- Biological Evaluation122 topics
- Cancer112 topics
- Annulation81 topic
- Imidazoles81 topic
- Ketene Dithioacetal81 topic
- Oxazolones81 topic
- Antimicrobial Activity71 topic
- Quinoxaline71 topic
- Tubulin Inhibitors71 topic
- Vascular Targeting Agents71 topic
- Cyclooxygenase-2 Inhibitors61 topic
- Prostaglandins61 topic
- Antimicrobial51 topic
- IL-651 topic
- STAT351 topic
- Triazines51 topic
- Allergic Diseases41 topic
- Asthma41 topic
Where does Paul E. Bender work?
Paul E. Bender's main affiliation in the publication record is New Frontier, United States.
How many publications and citations does Paul E. Bender have?
OpenAlex counts 51 works and 1,328 citations for Paul E. Bender, an h-index of 19, ranking #1,556,718 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul E. Bender. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.